ArticleAmerican journal of cancer research2018

Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma.

Jie-Xue Pan et al.PubMed ↗Full text ↗

No numbers read from the abstract.